LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. LianMedical - ADR market cap is $6.32M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. LianMedical - ADR 52 week high is $0.1768 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. LianMedical - ADR 52 week low is $0.0211 as of November 21, 2026.
LianMedical - ADR stock price today is $0.058.
LianMedical - ADR stock price yesterday was $0.0388.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. LianMedical - ADR 50-day moving average is $0.0523.